Expanding colorectal cancer patient support
December 05, 2017 08:20 ET
|
Colon Cancer Coalition
Minneapolis, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Minneapolis-based Colon Cancer Coalition and COLONTOWN®, a patient-led online community dedicated to patient, survivor, and caregiver support, are...
Reaching Young People with the Realities of Colorectal Cancer
November 21, 2017 09:12 ET
|
Colon Cancer Coalition
MINNEAPOLIS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- The number of colorectal cancer cases being diagnosed in young adults is on the rise. This holiday season the Colon Cancer Coalition is making the...
Veterans Turned Colorectal Cancer Warriors
November 10, 2017 11:30 ET
|
Colorectal Cancer Alliance
Washington, D.C., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Most people struggle their whole lives to find their true calling. Jennifer Kimmet and Dan Shockley are two veterans who have found it twice. Both...
eFFECTOR Therapeutics Presents Preclinical Data for eFT508 that Demonstrates Beneficial Immunological Effects
November 10, 2017 10:00 ET
|
EFFECTOR Therapeutics
SAN DIEGO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced a poster...
More than 150 Colorectal Cancer Patients, Survivors, and Caregivers to Take Part in the 15th Annual National Conference focused on Patient Empowerment
October 27, 2017 17:07 ET
|
Colon Cancer Alliance
Cleveland, OH, Oct. 27, 2017 (GLOBE NEWSWIRE) -- Now in its 15th year, the Colon Cancer Alliance’s annual National Conference will honor and celebrate colorectal patients and families, survivors,...
eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of eFT508 and Avelumab in Microsatellite Stable Colorectal Cancer
October 04, 2017 10:00 ET
|
EFFECTOR Therapeutics
SAN DIEGO, Oct. 04, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced it has...
Patient-Friendly Clinical Trials Finder Gives Access to Clinical Trials in Real-Time
July 11, 2017 16:03 ET
|
Colon Cancer Alliance
Washington, D.C., July 11, 2017 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE: July 11, 2017 Patient-Friendly Clinical Trials Finder Gives Access to Clinical Trials in Real-Time ...
Colorectal Cancer Nonprofits Partner to Grow Local Grassroots Advocacy
June 29, 2017 09:15 ET
|
Colon Cancer Coalition
Minneapolis, Minn. & Springfield, Mo., June 29, 2017 (GLOBE NEWSWIRE) -- The Colon Cancer Coalition and Fight Colorectal Cancer (Fight CRC) are working together to raise awareness of colorectal...
OncoMed Initiates Enrollment of Phase 1b Clinical Trial of Anti-DLL4/VEGF Bispecific Antibody as Second-line Treatment for Metastatic Colorectal Cancer Patients
January 04, 2017 08:30 ET
|
OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage company focused on discovering and developing novel anti-cancer stem cell and...
Companion Diagnostics Market worth 5.58 Billion USD by 2019; Transparency Market Research
September 27, 2016 08:03 ET
|
Transparency Market Research
Albany – New York, Sept. 27, 2016 (GLOBE NEWSWIRE) -- The global companion drugs market is expected to grow at 18.1% CAGR from 2013 to 2019 to reach US$5.58 bn by 2019. The market was worth...